Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European Heart Journal

• Publication date

  2018-12-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurheartj/ehx568PMID 29069341PMCID PMC6293269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• American Heart Association.

  2018cited by this paper
• Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

  2018influential reference
• What is precision medicine?

  2017cited by this paper
• CETP: Pharmacogenomics-Based Response to the CETP Inhibitor Dalcetrapib.

  2017cited by this paper
• Impact of Glycemic Variability on Chromatin Remodeling, Oxidative Stress, and Endothelial Dysfunction in Patients With Type 2 Diabetes and With Target HbA1c Levels

  2017cited by this paper
• The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels.

  2017cited by this paper
• Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach

  2017cited by this paper
• Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice

  2017cited by this paper
• NET silencing by let-7i in postural tachycardia syndrome.

  2017cited by this paper
• Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease

  2017influential reference
• PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients

  2016cited by this paper
• TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke

  2016cited by this paper
• TRAF 3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke

  2016cited by this paper
• Genome variation in precision medicine

  2016cited by this paper
• Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

  2016cited by this paper
• The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53‐Dependent Mechanism

  2016cited by this paper
• Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets?

  2016influential reference
• Precision medicine in cardiology

  2016cited by this paper
• Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation

  2016cited by this paper
• Saturation analysis for whole-genome bisulfite sequencing data

  2016cited by this paper
• Epigenome-wide association study of triglyceride postprandial responses to a high-fat dietary challenge

  2016cited by this paper
• Functions of microRNA-33a/b and microRNA therapeutics.

  2016cited by this paper
• Epigenetics of Lipid Phenotypes

  2016cited by this paper
• Single-Cell Resolution of Temporal Gene Expression during Heart Development.

  2016cited by this paper
• Epigenetic Changes in Diabetes and Cardiovascular Risk.

  2016cited by this paper
• Signature of circulating microRNAs in patients with acute heart failure

  2016cited by this paper
• Precision medicine

  2016cited by this paper
• Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery

  2016influential reference
• Information recovery from low coverage whole-genome bisulfite sequencing

  2016cited by this paper
• Altered Expression of Long Noncoding RNAs in Blood After Ischemic Stroke and Proximity to Putative Stroke Risk Loci

  2016cited by this paper
• Enhancing Human Cardiomyocyte Differentiation from Induced Pluripotent Stem Cells with Trichostatin A.

  2016cited by this paper
• Epigenome-wide association study reveals differential DNA methylation in individuals with a history of myocardial infarction.

  2016cited by this paper
• The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans

  2015cited by this paper
• Targeting chromatin remodeling to prevent cardiovascular disease in diabetes.

  2015cited by this paper
• Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans.

  2015cited by this paper
• Adverse Epigenetic Signatures by Histone Methyltransferase Set7 Contribute to Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus

  2015cited by this paper
• Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation

  2015cited by this paper
• Conrad Waddington and the origin of epigenetics

  2015cited by this paper
• MicroRNAs in myocardial infarction

  2015cited by this paper
• Past, present, and future of epigenetics applied to livestock breeding

  2015cited by this paper
• Future Translational Applications From the Contemporary Genomics Era: A Scientific Statement From the American Heart Association

  2015cited by this paper
• Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib

  2015cited by this paper
• Protective effects of sirtuins in cardiovascular diseases: from bench to bedside

  2015cited by this paper
• Circulating microRNAs and Outcome in Patients with Acute Heart Failure

  2015cited by this paper
• Transplantation of Epigenetically Modified Adult Cardiac c‐Kit+ Cells Retards Remodeling and Improves Cardiac Function in Ischemic Heart Failure Model

  2015cited by this paper
• Molecular pathways of arterial aging.

  2015cited by this paper
• Using "big data" to dissect clinical heterogeneity.

  2015cited by this paper
• Long Noncoding RNAs in Patients With Acute Myocardial Infarction

  2014cited by this paper
• Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal.

  2014cited by this paper
• Specific inhibition of HDAC4 in cardiac progenitor cells enhances myocardial repairs.

  2014cited by this paper
• Circulating MicroRNAs as Biomarkers of Acute Stroke

  2014cited by this paper
• Age-related clonal hematopoiesis associated with adverse outcomes.

  2014cited by this paper
• Epigenome-Wide Association Study of Fasting Blood Lipids in the Genetics of Lipid-Lowering Drugs and Diet Network Study

  2014cited by this paper
• Epigenetics of aging and aging-related disease.

  2014cited by this paper
• Epigenetic mechanisms underlying cardiac degeneration and regeneration.

  2014cited by this paper
• MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage.

  2014cited by this paper
• Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging.

  2013cited by this paper
• AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics.

  2013cited by this paper
• Alterations in cardiac DNA methylation in human dilated cardiomyopathy

  2013cited by this paper
• Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients

  2013cited by this paper
• MicroRNAs in Endothelial Senescence and Atherosclerosis

  2013cited by this paper
• SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands together.

  2013cited by this paper
• The Quantified Self: Fundamental Disruption in Big Data Science and Biological Discovery

  2013cited by this paper
• A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction

  2013influential reference
• Transcriptional regulation by the Set7 lysine methyltransferase

  2013cited by this paper
• MicroRNAs in Myocardial Infarction

  2013cited by this paper
• A Genome-Wide Methylation Study on Essential Hypertension in Young African American Males

  2013cited by this paper
• Epigenetic signatures and vascular risk in type 2 diabetes: a clinical perspective.

  2013cited by this paper
• The Endothelium Abridges Insulin Resistance to Premature Aging

  2013cited by this paper
• Endothelial Dysfunction : Consequence and Predictor of Insulin Resistance and Metabolic Diseases

  2013cited by this paper
• SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory

  2013cited by this paper
• Inhibition of Histone Deacetylase-induced Myocardial Repair Is Mediated by c-kit in Infarcted Hearts*

  2012cited by this paper
• Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1.

  2012cited by this paper
• Enhanced Angiogenic and Cardiomyocyte Differentiation Capacity of Epigenetically Reprogrammed Mouse and Human Endothelial Progenitor Cells Augments Their Efficacy for Ischemic Myocardial Repair

  2012cited by this paper
• Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide

  2012cited by this paper
• Environmental exposures, epigenetics and cardiovascular disease

  2012cited by this paper
• Use of circulating microRNAs to diagnose acute myocardial infarction.

  2012cited by this paper
• Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease.

  2012cited by this paper
• In Vitro Epigenetic Reprogramming of Human Cardiac Mesenchymal Stromal Cells into Functionally Competent Cardiovascular Precursors

  2012cited by this paper
• Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial

  2012cited by this paper
• Therapeutic potential for HDAC inhibitors in the heart.

  2012cited by this paper
• Distinct Epigenomic Features in End-Stage Failing Human Hearts

  2011cited by this paper
• DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy

  2011cited by this paper
• Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

  2011cited by this paper
• MicroRegulators come of age in senescence.

  2011cited by this paper
• Improvement of Cardiac Function in Mouse Myocardial Infarction after Transplantation of Epigenetically-Modified Bone Marrow Progenitor Cells

  2011cited by this paper
• Charting a course for genomic medicine from base pairs to bedside

  2011cited by this paper
• Histone Deacetylase Inhibition Enhances Self Renewal and Cardioprotection by Human Cord Blood-Derived CD34+ Cells

  2011cited by this paper
• Cardiovascular Epigenetics: Basic Concepts and Results From Animal and Human Studies

  2010cited by this paper
• Genetic control of individual differences in gene-specific methylation in human brain.

  2010cited by this paper
• Valproic acid enhances Oct4 promoter activity in myogenic cells

  2010cited by this paper
• Profiles in Cardiovascular Science

  2010cited by this paper
• Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

  2010cited by this paper
• The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences.

  2010cited by this paper
• Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes

  2010cited by this paper
• DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific.

  2009cited by this paper
• Trichostatin A treatment of cloned mouse embryos improves constitutive heterochromatin remodeling as well as developmental potential to term

  2009cited by this paper
• Decline in genomic DNA methylation through aging in a cohort of elderly subjects.

  2009cited by this paper
• Epigenetics and atherosclerosis.

  2009cited by this paper
• Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension.

  2008cited by this paper

• SIRT6 promotes angiogenesis by enhancing VEGFA secretion via demyristoylation in endothelial cell.

  2025cites this paper
• Human iPSC-derived salivary gland organoids model diabetic salivary gland dysfunction

  2025cites this paper
• Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure.

  2025cites this paper
• Targeting the Epigenetic Remodeler GCN5 Prevents Vascular Oxidative Stress and Endothelial Dysfunction in Obesity: Insights in Patients with Cardiometabolic Disease

  2025cites this paper
• Cardiovascular risk factors management in older adults: a clinical consensus statement from the European Association of Preventive Cardiology of the ESC and the ESC Council for Cardiology Practice.

  2025cites this paper
• Frontier technologies for investigating endothelial heterogeneity and function in diabetic vascular disease: An updated review.

  2025cites this paper
• Cardiometabolic heart failure with preserved ejection fraction: from molecular signatures to personalized treatment

  2025cites this paper
• Lactate Metabolism and Lactylation Modification: New Opportunities and Challenges in Cardiovascular Disease

  2025cites this paper
• miRNAs and T cell-mediated Immune Response in Disease

  2025cites this paper
• Landscape of Histone Posttranslational Modifications in Osteoarthritis

  2025cites this paper
• Association of the derived neutrophil-to-lymphocyte ratio with cardiovascular and all-cause mortality

  2025cites this paper
• Refining the link between obesity and heart failure: insights from GLP-1 receptor agonist trials and studies adopting direct adiposity measures

  2025cites this paper
• Natural Bioproducts with Epigenetic Properties for Treating Cardiovascular Disorders

  2025cites this paper
• Regulation of cardiac hypertrophy by RNA readers

  2025cites this paper
• SET7 lysine methyltransferase mediates the up-regulation of NADPH oxidase expression, oxidative stress, and NLRP3 inflammasome priming in atherosclerosis

  2025cites this paper
• Epigenetic mechanisms underlying the beneficial effects of cardiac rehabilitation. An overview from the working groups of "cellular and molecular biology of the heart" and "cardiac rehabilitation and cardiovascular prevention" of the Italian Society of Cardiology (SIC).

  2025cites this paper
• Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies

  2025cites this paper
• Targeting SETD7 Rescues Diabetes-induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin 3G.

  2025cites this paper
• The Role of Epigenetics in Cardiovascular Disease: Providing Insights into Disease Mechanisms and Evaluating Therapeutic Potential for Future Treatment Strategies

  2025cites this paper
• Role of physical activity in cardiovascular disease prevention: impact of epigenetic modifications

  2025influential citation
• Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches

  2025cites this paper
• Repressive H3K27me3 drives hyperglycemia-induced oxidative and inflammatory transcriptional programs in human endothelium

  2024cites this paper
• SGK1-Mediated Vascular Smooth Muscle Cell Phenotypic Transformation Promotes Thoracic Aortic Dissection Progression

  2024cites this paper
• Interplay of Reactive Oxygen Species (ROS) and Epigenetic Remodelling in Cardiovascular Diseases Pathogenesis: A Contemporary Perspective.

  2024cites this paper
• Epigenetic mechanisms in cardiovascular complications of diabetes: towards future therapies

  2024cites this paper
• What is the role of sex and gender in the future of precision cardiology?

  2024cites this paper
• Epidrugs in the clinical management of atherosclerosis: Mechanisms, challenges and promises.

  2024cites this paper
• Obstructive sleep apnea hypopnea syndrome and vascular lesions: An update on what we currently know.

  2024cites this paper
• RNA-mediated epigenetic regulation in exercised heart: Mechanisms and opportunities for intervention.

  2024cites this paper
• Epigenetic biomarkers for disease susceptibility and preventative medicine.

  2024cites this paper
• Mitochondrial miRNA as Epigenomic Signatures: Visualizing Aging-Associated Heart Diseases Through a New Lens.

  2023cites this paper
• Traditional Therapeutics and Potential Epidrugs for CVD: Why Not Both?

  2023cites this paper
• Epigenetic signals in heart failure: new opportunities for early diagnosis and eff ective therapy

  2023cites this paper
• Research progress on post-translational modification of proteins and cardiovascular diseases

  2023cites this paper
• Mitochondrial epigenetics in aging and cardiovascular diseases

  2023cites this paper
• SIRT6 is an epigenetic repressor of thoracic aortic aneurysms via inhibiting inflammation and senescence

  2023cites this paper
• Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies.

  2023cites this paper
• Understanding the nature of atherogenic disorders in children

  2023cites this paper
• Basic Pathogenic Mechanisms and Epigenetic Players Promoted by Extracellular Vesicles in Vascular Damage

  2023cites this paper
• DNA Methylation Is a Potential Biomarker for Cardiometabolic Health in Mexican Children and Adolescents

  2023cites this paper
• DNA methylation alternation in Stanford- A acute aortic dissection

  2022cites this paper
• Perspectives and future directions of translational epigenetics in personalized and precision medicine

  2022cites this paper
• Epigenetics and precision medicine in diabetes and obesity prevention and management

  2022cites this paper
• Epigenetic remodeling in heart failure with preserved ejection fraction

  2022cites this paper
• Epigenetics in Precision Nutrition

  2022cites this paper
• Advantageous early-life environments cushion the genetic risk for ischemic heart disease

  2022cites this paper
• Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via H3K9Ac inhibition

  2022cites this paper
• Potenciales de la nutrigenética en el abordaje y tratamiento de enfermedades cardiovasculares y factores de riesgo asociados

  2022cites this paper
• Studying Epigenetics of Cardiovascular Diseases on Chip Guide

  2022cites this paper
• Epi-Drugs in Heart Failure

  2022cites this paper
• Epigenetics in the primary and secondary prevention of cardiovascular disease: influence of exercise and nutrition.

  2022cites this paper
• Emerging epigenetic therapies of cardiac fibrosis and remodeling in heart failure: from basic mechanisms to early clinical development.

  2022cites this paper
• Modelling metabolic diseases and drug response using stem cells and organoids

  2022cites this paper
• Pharmacological Inhibition of Lysine-Specific Demethylase 1A Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice by a Mechanism Involving Decreased Oxidative Stress and Inflammation; Potential Implications in Human Atherosclerosis

  2022cites this paper
• Microfluidics for diagnosis and treatment of cardiovascular disease.

  2022cites this paper
• Endothelial Dysfunction and Chronic Inflammation: The Cornerstones of Vascular Alterations in Age-Related Diseases

  2022cites this paper
• African genetic diversity and adaptation inform a precision medicine agenda

  2021cites this paper
• Biophysics is reshaping our perception of the epigenome: from DNA-level to high-throughput studies

  2021cites this paper
• Disentangling the epigenetic landscape in cardiovascular patients: a path toward personalized medicine

  2021cites this paper
• Epigenetics in AUD and ACM.

  2021cites this paper
• [Personalized medicine in non-communicable diseases: latest advances and future prospects].

  2021cites this paper
• The BET Protein Inhibitor Apabetalone Rescues Diabetes-Induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1

  2021cites this paper
• PiRNA pathway in the cardiovascular system: a novel regulator of cardiac differentiation, repair and regeneration

  2021cites this paper
• Exploring RNA biomarkers in patients with acute myocarditis.

  2021cites this paper
• The Role of Computer Skills in Personal Health Record Adoption Among Patients With Heart Disease: Multidimensional Evaluation of Users Versus Nonusers

  2021influential citation
• Individual-specific functional epigenomics reveals genetic determinants of adverse metabolic effects of glucocorticoids.

  2021cites this paper
• Cell-specific epigenetic changes in atherosclerosis

  2021cites this paper
• Histone modifications in cardiovascular disease initiation and progression

  2021cites this paper
• Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies.

  2021cites this paper
• Using machine learning approaches for multi-omics data analysis: A review.

  2021cites this paper
• The Therapeutic Potential of Epigenome-Modifying Drugs in Cardiometabolic Disease

  2021cites this paper
• The Epigenome in Atherosclerosis.

  2021cites this paper
• The Role of Computer Skills in Personal Health Record Adoption Among Patients With Heart Disease: Multidimensional Evaluation of Users Versus Nonusers (Preprint)

  2020cites this paper
• Disentangling the epigenetic landscape in cardiovascular patients: a path toward personalized medicine.

  2020cites this paper
• Epigenetic Remodeling in Obesity-Related Vascular Disease

  2020cites this paper
• The vascular epigenome in patients with obesity and type 2 diabetes: opportunities for personalized therapies

  2020cites this paper
• When Good Guys Turn Bad: Bone Marrow’s and Hematopoietic Stem Cells’ Role in the Pathobiology of Diabetic Complications

  2020cites this paper
• JMJD1A Represses the Development of Cardiomyocyte Hypertrophy by Regulating the Expression of Catalase

  2020cites this paper
• Apabetalone - BET protein inhibition in cardiovascular disease and Type 2 diabetes.

  2020cites this paper
• Epigenetics in atherosclerosis: key features and therapeutic implications

  2020cites this paper
• From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases.

  2020cites this paper
• Precision medicine in distinct heart failure phenotypes: Focus on clinical epigenetics.

  2020cites this paper
• Epigenetic Control of Mitochondrial Function in the Vasculature

  2020cites this paper
• A Pilot Study on the Effects of l-Carnitine and Trimethylamine-N-Oxide on Platelet Mitochondrial DNA Methylation and CVD Biomarkers in Aged Women

  2020cites this paper
• Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease.

  2020cites this paper
• Interaction Between microRNA and DNA Methylation in Atherosclerosis

  2020cites this paper
• Inflammation: a common contributor to cancer, aging, and cardiovascular diseases—expanding the concept of cardio-oncology

  2019cites this paper
• Noise, pollution, food, or medication: what really matters in primary prevention?

  2019cites this paper
• Conclusions and perspectives: Major challenges and future prospects for prognostic epigenetics

  2019cites this paper
• Epigenetic mechanisms of vascular dysfunction in obesity and type 2 diabetes

  2019cites this paper
• Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis

  2019cites this paper
• Pathoepigenetics: The Role of Epigenetic Biomarkers in Disease Pathogenesis

  2019cites this paper
• Machine-learning to stratify diabetic patients using novel cardiac biomarkers and integrative genomics

  2019cites this paper
• Novel cardiovascular risk factors: air pollution, air temperature, pain, and sleep duration.

  2019cites this paper
• An overview of the molecular mechanisms underlying development and progression of bicuspid aortic valve disease.

  2019cites this paper
• High-intensity interval training modulates retinal microvascular phenotype and DNA methylation of p66Shc gene: a randomized controlled trial (EXAMIN AGE).

  2019cites this paper
• Forgotten cardiovascular risk factors: pregnancy complications and preterm birth, bullying, periodontal disease, and hypoxic burden.

  2019cites this paper
• Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

  2019cites this paper
• CHIPping Away at the Pathogenesis of Heart Failure.

  2019cites this paper
• Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy

  2019cites this paper